CHOP and Penn have received a transformational donation so that the research arm of Penn and a clinical arm of CHOP can converge. This will allow for very promising research and gene therapy to move to clinical trial. Targeted treatments and cures are within reach.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.